SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-19-009058
Filing Date
2019-04-23
Accepted
2019-04-23 17:27:34
Documents
2
Period of Report
2019-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2329
2 EXHIBIT 21.1 - POWER OF ATTORNEY poa_soland.htm EX-24.1 6466
  Complete submission text file 0001567619-19-009058.txt   10483
Mailing Address 4560 HORTON STREET,M/S R-422 EMERYVILLE CA 94608
Business Address
SOLAND DANIEL B (Reporting) CIK: 0001318485 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36830 | Film No.: 19762248

Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations